Completed NA INTERVENTIONAL NCT00165386

MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients

MRI-guided Bone Marrow Biopsies of Advanced CaP Patients

Sponsor: Dana-Farber Cancer Institute

Interventions Bone Marrow Biopsy Magnetic Resonance Imaging

Updated 5 times since 2017 Last updated: Dec 7, 2009 Started: Jul 31, 2001 Primary completion: Jan 31, 2006 Completion: Jan 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00165386, this NA trial focuses on Prostate Cancer and remains completed. Sponsored by Dana-Farber Cancer Institute, it has been updated 5 times since 2001, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jul 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dana-Farber Cancer Institute

Data source: Dana-Farber Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States